Zomedica Enhances TRUFORMA Platform with Feline Assay Extension

Zomedica Corp. has announced the expansion of its TRUFORMA diagnostic platform by including feline testing for its cobalamin and folate assay. Initially launched in 2024 for dogs, this multiplexed assay is unique in offering both cobalamin and folate testing in-clinic. Veterinarians had previously expressed a need to extend this testing to cats.

Deborah Greco, DVM, emphasized the importance of timely results for feline patients with gastrointestinal disease, noting rapid deterioration compared to canines. With the ability to receive results in under 25 minutes, the platform allows for immediate adjustment of treatment.

Michael Mockler, Zomedica's Senior Product Manager, highlighted the efficiency and practice profitability that the TRUFORMA platform offers. This expansion signifies a crucial advancement in veterinary diagnostic capabilities.